Behavioral Wire is an independent publication covering mental health as an industry.
Our reporting follows the intersection of science, regulation, clinical development, capital, markets, and care delivery. We cover the institutions, companies, researchers, regulators, and operators shaping how mental health treatments are developed, financed, governed, and delivered.
Behavioral Wire is written for people who need to understand not only what happened, but what changed and why it matters.
Why this publication exists
Mental health is increasingly shaped by forces that are often examined separately: drug development, clinical research, regulation, reimbursement, capital markets, technology, and changes in care delivery.
Behavioral Wire brings those developments into a single field of view.
Our goal is to make serious industry information easier to follow, compare, and understand across the field. That means reporting individual developments while also examining how evidence, policy, markets, and institutions are changing over time.
We believe high-quality information about mental health research, regulation, markets, and industry should be broadly accessible. Behavioral Wire's core reporting is available without a paywall so that researchers, clinicians, operators, investors, policymakers, journalists, and other readers can work from the same underlying information.
What we cover
Psychiatry and CNS therapeutics. Drug development, clinical trials, FDA decisions, novel mechanisms, established treatment categories, reimbursement, and the commercial development of psychiatric medicines.
Psychedelics. Psilocybin, MDMA, ibogaine, ketamine and related approaches. Clinical development, academic research, regulated-access programs, federal and state policy, and the companies and institutions operating across the field.
Cannabinoids and cannabis. Cannabinoid therapeutics, research, federal and state regulation, rescheduling, pharmaceutical development, market structure, and the relationship between cannabis policy and mental health.
Digital mental health and AI. Telehealth psychiatry, therapy platforms, digital therapeutics, AI-enabled mental health products, reimbursement, regulation, and changing models of behavioral-health delivery.
Behavioral-health delivery. Provider models, reimbursement, access, consolidation, telehealth, and the systems through which mental-health care reaches patients.
Regulation, markets, and research. Behavioral Wire tracks developments across agencies, clinical research, public companies, financing, policy, and other sources that can materially change the field.
How we work
Behavioral Wire combines reporting, careful research, source verification, and analysis.
Our work is grounded in primary sources wherever possible, including regulatory records, clinical-trial registries, scientific publications, company filings, government documents, and direct source reporting. Claims, numbers, dates, and material relationships are checked before publication, and analysis is kept distinct from reported fact.
News reporting is held to the standards described in our Methodology. Analysis and opinion are labeled so readers can distinguish reporting from interpretation.
We do not accept payment in exchange for editorial coverage. Commercial relationships, if introduced in the future, will remain separate from editorial decisions.
Relevant conflicts or affiliations are disclosed on our Disclosures page and, where appropriate, at the article level.
Who reads Behavioral Wire
Behavioral Wire is built for people working across the mental-health industry and the institutions around it, including investors, operators, clinicians, researchers, regulators, policymakers, and journalists.
The publication is designed for professional and informational use. It does not provide medical advice or individual treatment recommendations.
For personal mental-health support or treatment information, readers should consult qualified healthcare providers and appropriate public-health resources.
If you are experiencing a mental-health crisis in the United States, call or text 988 to reach the 988 Suicide & Crisis Lifeline.
Contact
For story tips, corrections, source outreach, partnership inquiries, or other questions, please use our Contact page.
Confidential source communications can also be arranged through the Contact page.
Behavioral Wire is an independent publication.